Advertisement

Topics

Janssen's Sirukumab Brings Mortality Imbalance Into FDA Panel Review

18:56 EDT 31 Jul 2017 | SCRIP

Unfavorable trends in all-cause death, malignancy and major adverse cardiovascular events are key safety issues facing US agency's Arthritis Advisory...

      

Related Stories

 

Original Article: Janssen's Sirukumab Brings Mortality Imbalance Into FDA Panel Review

NEXT ARTICLE

More From BioPortfolio on "Janssen's Sirukumab Brings Mortality Imbalance Into FDA Panel Review"

Quick Search
Advertisement
 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...